In the pharmacological treatment of a patient with mixed dyslipidemia to reduce cardiovascular mortality, which of the following statement is CORRECT?
The pathogenesis of hyperglycemia in type 2 diabetes includes all the following mechanisms except for:
Which statement best describes the differences between the characteristics of type 1 and type 2 diabetes:
Which of the following is not a beneficial effect of exercise in people with diabetes?
Which of the following are the recommended blood pressure and lipid goals for the prevention of cardiovascular disease in adults with diabetes?
According to the recommendations for the nutritional management of patients with diabetes, the consumption of saturated fat should be:
With regards to the control of blood pressure, which of the following is correct?
About the action of Glucagon-like peptide-1 (GLP-1), which of the following action is CORRECT?
Which anti-coagulant is preferred in the conservative management of NSTEMI?
Which of these factors is not a high risk for CVD?